News
US pharma major AbbVie recently announced top-line results from one of two parallel studies of the pivotal Phase III UP-AA ...
The cancer immunotherapy market is bracing for its next growth phase as bispecific T-cell engagers gain momentum, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback